BELLICUM INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investo - KFVS12 News & Weather Cape Girardeau, Carbondale, Poplar Bluff

BELLICUM INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Bellicum Pharmaceuticals, Inc. To Contact The Firm

NEW YORK, NY / ACCESSWIRE / February 13, 2018 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Bellicum Pharmaceuticals, Inc. (”Bellicum” or the ”Company”) (NASDAQ: BLCM).

Aftermarket on January 30, 2018, Bellicum issued a press release entitled ”Bellicum Pharmaceuticals Announces Clinical Hold on BPX-501 Clinical Trials in the United States[.]” Therein, the Company announced that it had ”received notice from the U.S. Food and Drug Administration (FDA) that U.S. studies of BPX-501 have been placed on a clinical hold following three cases of encephalopathy deemed as possibly related to BPX-501.” BPX-501 is the Company’s lead clinical product candidate designed to improve outcomes for patients undergoing stem cell transplant who lack a matched donor.

On this news, the Company’s share price fell from $8.20 per share on January 30, 2018 to a closing price of $6.08 on January 31, 2018 – a $2.12 or a 25.85% drop.

If you invested in Bellicum stock or options and would like to discuss your legal rights, click here: There is no cost or obligation to you.

You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to

685 Third Avenue, 26th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
Telephone: (877) 247-4292 or (212) 983-9330

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

SOURCE: Faruqi & Faruqi, LLP

ReleaseID: 489168

Information contained on this page is provided by an independent third-party content provider. Frankly and this Station make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact

Powered by Frankly